Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Genetic Profile × Clear all

Phase

Status

Unknown 2 Recruiting 2 Active not recruiting 2 Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 101 Cisplatin 100 Radiotherapy 99 pembrolizumab 92 Carboplatin 75 Paclitaxel 74 Gemcitabine 70 Nivolumab 67 Magnetic Resonance Spectroscopy 65 Fluorouracil 64 Dexamethasone 57 Bevacizumab 57 Radiosurgery 53 Docetaxel 52 Rituximab 48 Oxaliplatin 48 Leucovorin 47 fludarabine 45 Capecitabine 45 Biopsy 44 Doxorubicin 38 durvalumab 37 Drug Therapy 37 Cytarabine 35 fludarabine phosphate 34 Pemetrexed 34 Etoposide 34 Radiation 33 Lenalidomide 32 Specimen Handling 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03080428 2017-08-28

OPTIGEN

UNICANCER

Phase NA Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡